2008
Persistent and Relapsing Babesiosis in Immunocompromised Patients
Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, Furman RR, Neuhaus E, Skowron G, Gupta S, McCalla C, Pesanti EL, Young M, Heiman D, Hsue G, Gelfand JA, Wormser GP, Dickason J, Bia FJ, Hartman B, Telford SR, Christianson D, Dardick K, Coleman M, Girotto JE, Spielman A. Persistent and Relapsing Babesiosis in Immunocompromised Patients. Clinical Infectious Diseases 2008, 46: 370-376. PMID: 18181735, DOI: 10.1086/525852.Peer-Reviewed Original ResearchConceptsCase patientsAntibabesial treatmentClinical courseControl subjectsBlood smearsRetrospective case-control studyOptimal treatment regimenStandard antimicrobial therapyMalaria-like illnessBabesia microti infectionMost cases patientsCase-control studyCourse of therapyB-cell lymphomaAdministration of atovaquoneImmunologic statusStandard therapyAntimicrobial regimenSuch patientsTreatment regimenMicroti infectionAntimicrobial therapyPersistent infectionCell lymphomaAcute babesiosis
2007
Fellows’ Forum in Dialysis :edited by Mark A. Perazella: Nontuberculous Mycobacterial Peritonitis in Peritoneal Dialysis Patients
Rho M, Bia F, Brewster UC. Fellows’ Forum in Dialysis :edited by Mark A. Perazella: Nontuberculous Mycobacterial Peritonitis in Peritoneal Dialysis Patients. Seminars In Dialysis 2007, 20: 271-276. PMID: 17555495, DOI: 10.1111/j.1525-139x.2007.00289.x.Peer-Reviewed Case Reports and Technical NotesConceptsPeritoneal dialysis patientsMycobacterial peritonitisDialysis patientsSerious intra-abdominal complicationsMark A. PerazellaPrompt catheter removalIntra-abdominal complicationsCases of peritonitisPatient risk factorsManagement of PDCatheter removalPrompt diagnosisTherapeutic challengeRisk factorsAntimicrobial therapyUnique presentationAppropriate diagnosisMycobacterial infectionTreatment strategiesPeritonitisMycobacterium chelonaeInfectionDiagnosisMycobacterium gordonaePatients